Behavioral and Cellular Neuroscience, Department of Psychological and Brain Sciences, Texas A&M University, 4235 TAMU, College Station, TX 77843, USA.
Department of Veterinary Physiology and Pharmacology, Texas A&M University, 4466 TAMU, College Station, TX 77843-4466, USA.
J Affect Disord. 2023 Jul 15;333:409-419. doi: 10.1016/j.jad.2023.04.044. Epub 2023 Apr 19.
Obese females are more likely to suffer from depression and are also more likely to be resistant to current medications. This study examined the potential antidepressant-like effects of 1,4-dihydroxy-2-napthoic acid (DHNA), a selective aryl hydrocarbon receptor modulator (SAhRM), in obese female mice.
Obesity was established by feeding C57BL/6N female mice a high fat diet (HFD) for 9-10 weeks. Subsequently, mice were subjected to unpredictable chronic mild stress (UCMS) or remained unstressed. Daily administration of vehicle or 20 mg/kg DHNA began three weeks prior or on the third week of UCMS. Mice were examined for depression-like behaviors (sucrose preference, forced swim test (FST), splash and tape groom tests), anxiety (open-field test, light/dark test, novelty-induced hypophagia), and cognition (object location recognition, novel object recognition, Morris water maze).
UCMS did not alter, and DHNA slightly increased, weight gain in HFD-fed females. HFD decreased sucrose preference, increased FST immobility time, but did not alter splash and tape tests' grooming time. UCMS did not have additional effects on sucrose preference. UCMS further increased FST immobility time and decreased splash and tape tests' grooming time; these effects were prevented and reversed by DHNA treatment. HFD did not affect behaviors in the cognitive tests. UCMS impaired spatial learning; this effect was not prevented nor reversed by DHNA.
DHNA protected against UCMS-induced depression-like behaviors in HFD-fed female mice. DHNA neither improved nor worsened UCMS-induced impairment of spatial learning. Our findings indicate that DHNA has high potential to act as an antidepressant in obese females.
肥胖女性更容易患抑郁症,并且对目前的药物治疗也更具抵抗力。本研究探讨了 1,4-二羟基-2-萘甲酸(DHNA)作为一种选择性芳烃受体调节剂(SAhRM),对肥胖雌性小鼠的潜在抗抑郁作用。
通过给 C57BL/6N 雌性小鼠喂食高脂肪饮食(HFD)9-10 周来建立肥胖模型。随后,将小鼠置于不可预测的慢性轻度应激(UCMS)或保持未应激状态。在 UCMS 的第 3 周之前或第 3 周开始,每天给予载体或 20mg/kg 的 DHNA 进行治疗。通过蔗糖偏好测试、强迫游泳测试(FST)、飞溅和胶带梳理测试,观察小鼠的抑郁样行为;通过旷场测试、明暗测试、新奇性诱导的摄食减少实验,观察焦虑行为;通过物体位置识别测试、新物体识别测试、Morris 水迷宫实验,观察认知功能。
UCMS 没有改变 HFD 喂养的雌性小鼠的体重增加,而 DHNA 则轻微增加了体重增加。HFD 降低了蔗糖偏好,增加了 FST 不动时间,但没有改变飞溅和胶带测试的梳理时间。UCMS 对蔗糖偏好没有额外的影响。UCMS 进一步增加了 FST 不动时间,并减少了飞溅和胶带测试的梳理时间;DHNA 处理可预防和逆转这些影响。HFD 不影响认知测试中的行为。UCMS 损害了空间学习能力;DHNA 既没有预防也没有逆转这种影响。
DHNA 可预防 HFD 喂养的雌性小鼠发生 UCMS 诱导的抑郁样行为。DHNA 既没有改善也没有恶化 UCMS 诱导的空间学习障碍。我们的研究结果表明,DHNA 很有可能成为肥胖女性的抗抑郁药物。